Literature DB >> 22388737

Topoisomerase I poisoning results in PARP-mediated replication fork reversal.

Arnab Ray Chaudhuri1, Yoshitami Hashimoto, Raquel Herrador, Kai J Neelsen, Daniele Fachinetti, Rodrigo Bermejo, Andrea Cocito, Vincenzo Costanzo, Massimo Lopes.   

Abstract

Topoisomerase I (Top1) releases torsional stress during DNA replication and transcription and is inhibited by camptothecin and camptothecin-derived cancer chemotherapeutics. Top1 inhibitor cytotoxicity is frequently linked to double-strand break (DSB) formation as a result of Top1 being trapped on a nicked DNA intermediate in replicating cells. Here we use yeast, mammalian cell lines and Xenopus laevis egg extracts to show that Top1 poisons rapidly induce replication-fork slowing and reversal, which can be uncoupled from DSB formation at sublethal inhibitor doses. Poly(ADP-ribose) polymerase activity, but not single-stranded break repair in general, is required for effective fork reversal and limits DSB formation. These data identify fork reversal as a means to prevent chromosome breakage upon exogenous replication stress and implicate proteins involved in fork reversal or restart as factors modulating the cytotoxicity of replication stress-inducing chemotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22388737     DOI: 10.1038/nsmb.2258

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  41 in total

1.  Positive torsional strain causes the formation of a four-way junction at replication forks.

Authors:  L Postow; C Ullsperger; R W Keller; C Bustamante; A V Vologodskii; N R Cozzarelli
Journal:  J Biol Chem       Date:  2000-10-30       Impact factor: 5.157

2.  Genome-organizing factors Top2 and Hmo1 prevent chromosome fragility at sites of S phase transcription.

Authors:  Rodrigo Bermejo; Thelma Capra; Victor Gonzalez-Huici; Daniele Fachinetti; Andrea Cocito; Gioacchino Natoli; Yuki Katou; Hiroshi Mori; Ken Kurokawa; Katsuhiko Shirahige; Marco Foiani
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

Review 3.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

4.  Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects.

Authors:  José M Sogo; Massimo Lopes; Marco Foiani
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

5.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

Authors:  Z Q Wang; B Auer; L Stingl; H Berghammer; D Haidacher; M Schweiger; E F Wagner
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

Review 6.  Next generation topoisomerase I inhibitors: Rationale and biomarker strategies.

Authors:  Beverly A Teicher
Journal:  Biochem Pharmacol       Date:  2007-10-22       Impact factor: 5.858

7.  The effect of inhibition of (ADP-ribose)n biosynthesis on DNA repair assayed by the nucleoid technique.

Authors:  B W Durkacz; S Shall; J Irwin
Journal:  Eur J Biochem       Date:  1981-12

8.  Replicon dynamics, dormant origin firing, and terminal fork integrity after double-strand break formation.

Authors:  Ylli Doksani; Rodrigo Bermejo; Simona Fiorani; James E Haber; Marco Foiani
Journal:  Cell       Date:  2009-04-09       Impact factor: 41.582

Review 9.  The DNA damage response and cancer therapy.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

10.  Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells.

Authors:  D A Jackson; A Pombo
Journal:  J Cell Biol       Date:  1998-03-23       Impact factor: 10.539

View more
  226 in total

1.  Fork rotation and DNA precatenation are restricted during DNA replication to prevent chromosomal instability.

Authors:  Stephanie A Schalbetter; Sahar Mansoubi; Anna L Chambers; Jessica A Downs; Jonathan Baxter
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

2.  Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.

Authors:  Yeonee Seol; Hongliang Zhang; Keli Agama; Nicholas Lorence; Yves Pommier; Keir C Neuman
Journal:  Mol Cancer Ther       Date:  2015-09-08       Impact factor: 6.261

3.  Tel1/ATM prevents degradation of replication forks that reverse after topoisomerase poisoning.

Authors:  Luca Menin; Sebastian Ursich; Camilla Trovesi; Ralph Zellweger; Massimo Lopes; Maria Pia Longhese; Michela Clerici
Journal:  EMBO Rep       Date:  2018-05-08       Impact factor: 8.807

Review 4.  Targeting Topoisomerase I in the Era of Precision Medicine.

Authors:  Anish Thomas; Yves Pommier
Journal:  Clin Cancer Res       Date:  2019-06-21       Impact factor: 12.531

Review 5.  Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).

Authors:  Yves Pommier; Shar-yin N Huang; Rui Gao; Benu Brata Das; Junko Murai; Christophe Marchand
Journal:  DNA Repair (Amst)       Date:  2014-05-22

6.  SLFN11 Blocks Stressed Replication Forks Independently of ATR.

Authors:  Junko Murai; Sai-Wen Tang; Elisabetta Leo; Simone A Baechler; Christophe E Redon; Hongliang Zhang; Muthana Al Abo; Vinodh N Rajapakse; Eijiro Nakamura; Lisa M Miller Jenkins; Mirit I Aladjem; Yves Pommier
Journal:  Mol Cell       Date:  2018-02-01       Impact factor: 17.970

7.  Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4.

Authors:  Yonghwan Kim; Gabriella S Spitz; Uma Veturi; Francis P Lach; Arleen D Auerbach; Agata Smogorzewska
Journal:  Blood       Date:  2012-10-23       Impact factor: 22.113

8.  Ca2+-Stimulated AMPK-Dependent Phosphorylation of Exo1 Protects Stressed Replication Forks from Aberrant Resection.

Authors:  Shan Li; Zeno Lavagnino; Delphine Lemacon; Lingzhen Kong; Alessandro Ustione; Xuewen Ng; Yuanya Zhang; Yingchun Wang; Bin Zheng; Helen Piwnica-Worms; Alessandro Vindigni; David W Piston; Zhongsheng You
Journal:  Mol Cell       Date:  2019-04-30       Impact factor: 17.970

9.  Regulation of Mus81-Eme1 Holliday junction resolvase in response to DNA damage.

Authors:  Pierre-Marie Dehé; Stéphane Coulon; Sarah Scaglione; Paul Shanahan; Arato Takedachi; James A Wohlschlegel; John R Yates; Bertrand Llorente; Paul Russell; Pierre-Henri L Gaillard
Journal:  Nat Struct Mol Biol       Date:  2013-04-14       Impact factor: 15.369

10.  Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition.

Authors:  Junko Murai; Yiping Zhang; Joel Morris; Jiuping Ji; Shunichi Takeda; James H Doroshow; Yves Pommier
Journal:  J Pharmacol Exp Ther       Date:  2014-03-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.